Status:
RECRUITING
Determination of Factors Involved in the Regulation of Immune Responses After Allogeneic Hematopoietic Stem Cell Transplantation
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Allogeneic Hematopoietic Stem Cell Transplantation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study concerns donors and patients receiving allogeneic stem cell haematopoietic transplantation. The aim of the study is to analyse HSC graft content in immune effector T (naive, memory, activate...
Eligibility Criteria
Inclusion
- patient of the Nancy CHRU, for whom a CSH allograft is planned. or
- hematopoietic stem cell donors received at Nancy's CHRU for the duration of the research
Exclusion
- Positive HIV
- active hepatitis B or C infection
Key Trial Info
Start Date :
October 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2026
Estimated Enrollment :
700 Patients enrolled
Trial Details
Trial ID
NCT03357172
Start Date
October 1 2019
End Date
September 30 2026
Last Update
October 14 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU de Nancy
Vandœuvre-lès-Nancy, France, 54511